SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma
Investigational New Drugs - Netherlands
doi 10.1007/s10637-011-9719-0
Full Text
Open PDFAbstract
Available in full text
Date
July 12, 2011
Authors
Publisher
Springer Science and Business Media LLC